<DOC>
	<DOCNO>NCT00000670</DOCNO>
	<brief_summary>To evaluate interaction probenecid zidovudine ( AZT ) . Because AZT eliminate quickly body , must take frequently . A previous study show probenecid slow elimination AZT without side effect , study last 5 day . This study see whether effect continue 1 month whether continuation probenecid AZT free side effect 1 month .</brief_summary>
	<brief_title>Safety Tolerance Zidovudine With Probenecid Effect Probenecid Zidovudine Pharmacokinetics Over Four Weeks</brief_title>
	<detailed_description>Because AZT eliminate quickly body , must take frequently . A previous study show probenecid slow elimination AZT without side effect , study last 5 day . This study see whether effect continue 1 month whether continuation probenecid AZT free side effect 1 month . Patients hospitalize overnight three separate occasion . On first admission , AZT administer every 4 hour . On second day , 15 blood sample take determine fast AZT enters remove bloodstream ( pharmacokinetics ) . On second day , blood specimen collect , patient start take probenecid mouth every 8 hour , discharge research unit . The AZT dose take every 8 hour . One week later 3 week , patient readmitted overnight blood sample measure AZT level repeat . AMENDED : 8 additional patient enrol use dos AZT low dose probenecid .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Interferon . Aerosolized pentamidine Pneumocystis carinii pneumonia ( PCP ) prophylaxis . Concurrent Treatment : Allowed : Radiation skin lesion . Patients symptomatic HIV infection take zidovudine ( AZT ) five six time day therapy . Includes patient AIDS history cytologically confirm Pneumocystis carinii pneumonia ( PCP ) , patient advance AIDS relate complex ( ARC ) , HIV antibody positive patient . Patients must able give write informed consent . Exclusion Criteria Coexisting Condition : Patients follow exclude : Allergy probenecid . Any underlying medical condition sufficient , investigator 's opinion , prevent adequate compliance study therapy . History urinary tract urate stone gout . Becoming acutely ill , unstable , febrile . Concurrent Medication : Excluded : Methotrexate . Antiretroviral drug . Ganciclovir . Amphotericin . Experimental drug . Isoniazid . Pyrazinamide . Flucytosine . Intravenous pentamidine . Dapsone . Fansidar . Antineoplastic drug specifically allow . Trimethoprim / sulfamethoxazole . Valproic acid . Opiates . Rifampin . Sulfonylureas . Concurrent Treatment : Excluded : Radiation specifically allow . Patients follow exclude : Allergy probenecid . Any underlying medical condition sufficient , investigator 's opinion , prevent adequate compliance study therapy . History urinary tract urate stone gout . Becoming acutely ill , unstable , febrile .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Probenecid</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Interactions</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>